BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38736082)

  • 1. Digital Gangrene as a Paraneoplastic Manifestation of Peripheral T-cell Lymphoma Not Otherwise Specified Type.
    Madhuram GS; Geetha T; Bharathiraja G; Arunkumar P; Prabagar M; Subramaniam K
    J Assoc Physicians India; 2024 Jan; 72(1):99-102. PubMed ID: 38736082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acral vascular syndrome Lennert type T cell lymphoma-a case report.
    Klanidhi KB; Monian SA; Chakrawarty A
    J Egypt Natl Canc Inst; 2021 Mar; 33(1):8. PubMed ID: 33661406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital Gangrene: An Unusual Manifestation of Non-Hodgkin Lymphoma.
    Momen Majumder MS; Ahmed S; Haque T; Haq SA; Chakravarty S; Shahin MA; Osmany DMF; Rasker JJ
    Case Rep Vasc Med; 2022; 2022():8963753. PubMed ID: 35284148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome?
    Pileri A; Pellegrini C; Agostinelli C; Grandi V; Patrizi A; Zinzani PL; Pimpinelli N
    Eur J Dermatol; 2017 Feb; 27(1):49-53. PubMed ID: 27873737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sub-acute demyelinating polyradiculoneuropathy as an initial symptom of peripheral T cell lymphoma, not otherwise specified (PTCL-NOS).
    Kawanishi K; Ohyama Y; Kanai Y; Hirase T; Tanaka H; Miyatake J; Tatsumi Y; Ashida T; Nakamine H; Matsumura I
    Intern Med; 2012; 51(15):2015-20. PubMed ID: 22864129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CHOP with THP-COP for peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective analysis using data from the population-based Osaka Cancer Registry.
    Kida S; Fuji S; Morishima T; Nakata K; Miyashiro I; Ishikawa J
    Int J Hematol; 2021 Aug; 114(2):246-251. PubMed ID: 33864237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Small cell variant of peripheral T-cell lymphoma, not otherwise specified: a clinicopathologic and immunophenotypic analysis].
    Li YL; Liu WP; Tang Y; Zhao S; Zuo Z; Yang YH; Yang QP; Luo TY
    Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):323-8. PubMed ID: 19575875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aggressive peripheral T-cell lymphomas: 2013.
    Armitage JO
    Am J Hematol; 2013 Oct; 88(10):910-8. PubMed ID: 24078271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
    Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
    Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature.
    Sekiguchi Y; Shirane S; Shimada A; Ichikawa K; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2015; 8(4):4186-203. PubMed ID: 26097612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral T-Cell Lymphoma Presenting as a Primary Uterine Cervix Mass: A Report of a Rare Case.
    Kosari F; Niknejad N; Nili F; Jahanbin B; Malek M
    Int J Gynecol Pathol; 2017 Nov; 36(6):523-527. PubMed ID: 28244895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and capillaroscopic regression of CD30 anaplastic lymphoma associated with limited cutaneous systemic sclerosis following autologous bone marrow transplantation].
    Bellis R; Francès C; Barète S; Senet P
    Ann Dermatol Venereol; 2014; 141(6-7):446-51. PubMed ID: 24951144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical and economic burden of peripheral T-cell lymphoma: a systematic literature review.
    Ashaye AO; Burnett H; Abogunrin S; Panchmatia H; Ovcinnikova O; Dalal M
    Future Oncol; 2022 Feb; 18(4):519-535. PubMed ID: 34851173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary manifestations of peripheral T-cell lymphoma: case report and review of the literature.
    Vahid B; Machare-Delgado E; Marik PE
    Clin Respir J; 2007 Dec; 1(2):114-7. PubMed ID: 20298290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive external ophthalmoplegia: a paraneoplastic manifestation of lymphoma.
    Ascaso FJ; Torres M; Bergua JM; Alvarez R; Cristóbal JA
    Eur J Ophthalmol; 2002; 12(4):315-8. PubMed ID: 12220003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, risk factors and outcome of digital gangrene in 2684 lupus patients.
    Liu A; Zhang W; Tian X; Zhang X; Zhang F; Zeng X
    Lupus; 2009 Oct; 18(12):1112-8. PubMed ID: 19762389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade.
    Gambichler T; Strutzmann S; Tannapfel A; Susok L
    BMC Cancer; 2017 May; 17(1):327. PubMed ID: 28499411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.
    Gleeson M; Peckitt C; To YM; Edwards L; Oates J; Wotherspoon A; Attygalle AD; Zerizer I; Sharma B; Chua S; Begum R; Chau I; Johnson P; Ardeshna KM; Hawkes EA; Macheta MP; Collins GP; Radford J; Forbes A; Hart A; Montoto S; McKay P; Benstead K; Morley N; Kalakonda N; Hasan Y; Turner D; Cunningham D
    Lancet Haematol; 2018 May; 5(5):e190-e200. PubMed ID: 29703335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified.
    Hayashino K; Yoshida C; Ayata Y; Yukawa R; Komura A; Nakamura M; Meguri Y; Yamamoto K; Oda W; Imajo K
    J Clin Exp Hematop; 2024; 64(1):52-58. PubMed ID: 38538319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
    Shibata Y; Hara T; Kasahara S; Yamada T; Sawada M; Mabuchi R; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Kanemura N; Kito Y; Goto N; Miyazaki T; Takami T; Takeuchi T; Shimizu M; Tsurumi H
    Hematol Oncol; 2017 Jun; 35(2):163-171. PubMed ID: 26449182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.